Clinical Infectious Disease: 44°C局部热疗可有效清除宫颈高危人乳头瘤病毒

2021-11-08 MedSci原创 MedSci原创

HPV一般指人乳头瘤病毒。 人乳头瘤病毒是一种属于乳多空病毒科的乳头瘤空泡病毒A属,是球形DNA病毒,能引起人体皮肤黏膜的鳞状上皮增殖。

       高危 (HR) 人乳头瘤病毒 (HPV) 是宫颈癌的主要致病因素,全世界有5-30%的普通人群是宫颈HPV阳性,宫颈癌阳性患者中高达99.7%的患者是上皮内瘤变 (CIN) 。由于大多数感染病例是一过性的,60%的HPV感染在1年内自发消退,90%在2年内自行消退,很少有持续感染病例并最终发展成癌症。对于已经感染HPV或错过推荐接种年龄的女性,预防性疫苗接种是无效的。目前对可见 HPV 感染所致病变的常规治疗包括环电外科切除术 (LEEP)、冷刀锥切术和手术切除术。外源性组织温度升高已被用作放射疗法的伴随疗法用于治疗宫颈肿瘤,并已被证明可以改善患者的预后。之前的随机试验表明,与安慰剂治疗相比,44ºC局部热疗在治疗HPV感染的足底疣方面取得了更高的治愈率。因此,本项研究评估 44ºC高温对高危HPV清除的效果。

 

       研究人员在美国4个医疗中心进行了一项随机对照试验,招募了阳性高危 HPV 和正常或不显着的细胞学发现(意义不明的阴性/非典型鳞状细胞/低度鳞状上皮内病变)的患者。参与者被随机1:1接受 44ºC 或 37ºC 的热疗,每次治疗 30 分钟。两组患者均每天接受一次治疗,连续3天,10天后再加2次治疗。主要观察结果是治疗后3个月HPV的清除率。

 

       治疗3个月后,44ºC热疗组27名患者中的23名和37ºC治疗组26名患者中的13名分别清除了HPV。两组之间的 HPV 清除率存在统计学显着差异(85.19% vs 50%,P= .014)。在44ºC热疗治疗组失败的4名患者中,有2名在治疗前后具有相同的HPV类型(分别为 HPV51和HPV16)。而在治疗后,两人都保留了单一的 HPV 基因型(HPV53和HPV16)。考虑到 HPV16 在宫颈转化中的主导地位,研究人员强烈建议对HPV16保持阳性的 2 名患者进行活检。10人有原位癌,13 人为 CIN 2 级。在对照组的13名无反应者中,有10名患者仍保持与治疗前相同类型的HPV阳性。

 

        本项研究结果证实:44ºC局部热疗可以安全且显着地有助于清除宫颈高危患者的HPV感染,缩短患病患者的治疗构成,有利于预防疾病的进展,并有助于减轻患者对将病毒传播给他人的担忧。

 

 

原始出处:

Yang Yang. Et al. Local Hyperthermia at 44°C Is Effective in Clearing Cervical High-Risk Human Papillomaviruses: A Proof-of-Concept, Randomized Controlled Clinical Trial.Clinical Infectious Diseases.2021.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2013755, encodeId=1c442013e5537, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Sep 23 21:18:17 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716745, encodeId=84ef1e1674575, content=<a href='/topic/show?id=147c6e238cf' target=_blank style='color:#2F92EE;'>#热疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67238, encryptionId=147c6e238cf, topicName=热疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924b32313941, createdName=zhaohui6742, createdTime=Fri Dec 31 15:18:17 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086209, encodeId=c33920862095a, content=<a href='/topic/show?id=d85c13141c' target=_blank style='color:#2F92EE;'>#4°C#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1314, encryptionId=d85c13141c, topicName=4°C)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Sun Jun 12 17:18:17 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406116, encodeId=8d851406116ec, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47589, encryptionId=a5404e589d7, topicName=局部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d14c2562456, createdName=chg122, createdTime=Tue Nov 09 12:18:17 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408310, encodeId=2e0f140831051, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Tue Nov 09 12:18:17 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443502, encodeId=b099144350252, content=<a href='/topic/show?id=4a65246327c' target=_blank style='color:#2F92EE;'>#人乳头瘤病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24632, encryptionId=4a65246327c, topicName=人乳头瘤病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fb15077773, createdName=ms3297076796458174, createdTime=Tue Nov 09 12:18:17 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507808, encodeId=4ecb150e808d6, content=<a href='/topic/show?id=8764484014' target=_blank style='color:#2F92EE;'>#clinical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4840, encryptionId=8764484014, topicName=clinical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ee59933733, createdName=zll0628, createdTime=Tue Nov 09 12:18:17 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2013755, encodeId=1c442013e5537, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Sep 23 21:18:17 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716745, encodeId=84ef1e1674575, content=<a href='/topic/show?id=147c6e238cf' target=_blank style='color:#2F92EE;'>#热疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67238, encryptionId=147c6e238cf, topicName=热疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924b32313941, createdName=zhaohui6742, createdTime=Fri Dec 31 15:18:17 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086209, encodeId=c33920862095a, content=<a href='/topic/show?id=d85c13141c' target=_blank style='color:#2F92EE;'>#4°C#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1314, encryptionId=d85c13141c, topicName=4°C)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Sun Jun 12 17:18:17 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406116, encodeId=8d851406116ec, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47589, encryptionId=a5404e589d7, topicName=局部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d14c2562456, createdName=chg122, createdTime=Tue Nov 09 12:18:17 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408310, encodeId=2e0f140831051, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Tue Nov 09 12:18:17 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443502, encodeId=b099144350252, content=<a href='/topic/show?id=4a65246327c' target=_blank style='color:#2F92EE;'>#人乳头瘤病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24632, encryptionId=4a65246327c, topicName=人乳头瘤病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fb15077773, createdName=ms3297076796458174, createdTime=Tue Nov 09 12:18:17 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507808, encodeId=4ecb150e808d6, content=<a href='/topic/show?id=8764484014' target=_blank style='color:#2F92EE;'>#clinical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4840, encryptionId=8764484014, topicName=clinical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ee59933733, createdName=zll0628, createdTime=Tue Nov 09 12:18:17 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2013755, encodeId=1c442013e5537, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Sep 23 21:18:17 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716745, encodeId=84ef1e1674575, content=<a href='/topic/show?id=147c6e238cf' target=_blank style='color:#2F92EE;'>#热疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67238, encryptionId=147c6e238cf, topicName=热疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924b32313941, createdName=zhaohui6742, createdTime=Fri Dec 31 15:18:17 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086209, encodeId=c33920862095a, content=<a href='/topic/show?id=d85c13141c' target=_blank style='color:#2F92EE;'>#4°C#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1314, encryptionId=d85c13141c, topicName=4°C)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Sun Jun 12 17:18:17 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406116, encodeId=8d851406116ec, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47589, encryptionId=a5404e589d7, topicName=局部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d14c2562456, createdName=chg122, createdTime=Tue Nov 09 12:18:17 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408310, encodeId=2e0f140831051, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Tue Nov 09 12:18:17 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443502, encodeId=b099144350252, content=<a href='/topic/show?id=4a65246327c' target=_blank style='color:#2F92EE;'>#人乳头瘤病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24632, encryptionId=4a65246327c, topicName=人乳头瘤病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fb15077773, createdName=ms3297076796458174, createdTime=Tue Nov 09 12:18:17 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507808, encodeId=4ecb150e808d6, content=<a href='/topic/show?id=8764484014' target=_blank style='color:#2F92EE;'>#clinical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4840, encryptionId=8764484014, topicName=clinical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ee59933733, createdName=zll0628, createdTime=Tue Nov 09 12:18:17 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2022-06-12 yahu
  4. [GetPortalCommentsPageByObjectIdResponse(id=2013755, encodeId=1c442013e5537, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Sep 23 21:18:17 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716745, encodeId=84ef1e1674575, content=<a href='/topic/show?id=147c6e238cf' target=_blank style='color:#2F92EE;'>#热疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67238, encryptionId=147c6e238cf, topicName=热疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924b32313941, createdName=zhaohui6742, createdTime=Fri Dec 31 15:18:17 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086209, encodeId=c33920862095a, content=<a href='/topic/show?id=d85c13141c' target=_blank style='color:#2F92EE;'>#4°C#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1314, encryptionId=d85c13141c, topicName=4°C)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Sun Jun 12 17:18:17 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406116, encodeId=8d851406116ec, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47589, encryptionId=a5404e589d7, topicName=局部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d14c2562456, createdName=chg122, createdTime=Tue Nov 09 12:18:17 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408310, encodeId=2e0f140831051, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Tue Nov 09 12:18:17 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443502, encodeId=b099144350252, content=<a href='/topic/show?id=4a65246327c' target=_blank style='color:#2F92EE;'>#人乳头瘤病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24632, encryptionId=4a65246327c, topicName=人乳头瘤病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fb15077773, createdName=ms3297076796458174, createdTime=Tue Nov 09 12:18:17 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507808, encodeId=4ecb150e808d6, content=<a href='/topic/show?id=8764484014' target=_blank style='color:#2F92EE;'>#clinical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4840, encryptionId=8764484014, topicName=clinical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ee59933733, createdName=zll0628, createdTime=Tue Nov 09 12:18:17 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2021-11-09 chg122
  5. [GetPortalCommentsPageByObjectIdResponse(id=2013755, encodeId=1c442013e5537, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Sep 23 21:18:17 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716745, encodeId=84ef1e1674575, content=<a href='/topic/show?id=147c6e238cf' target=_blank style='color:#2F92EE;'>#热疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67238, encryptionId=147c6e238cf, topicName=热疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924b32313941, createdName=zhaohui6742, createdTime=Fri Dec 31 15:18:17 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086209, encodeId=c33920862095a, content=<a href='/topic/show?id=d85c13141c' target=_blank style='color:#2F92EE;'>#4°C#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1314, encryptionId=d85c13141c, topicName=4°C)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Sun Jun 12 17:18:17 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406116, encodeId=8d851406116ec, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47589, encryptionId=a5404e589d7, topicName=局部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d14c2562456, createdName=chg122, createdTime=Tue Nov 09 12:18:17 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408310, encodeId=2e0f140831051, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Tue Nov 09 12:18:17 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443502, encodeId=b099144350252, content=<a href='/topic/show?id=4a65246327c' target=_blank style='color:#2F92EE;'>#人乳头瘤病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24632, encryptionId=4a65246327c, topicName=人乳头瘤病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fb15077773, createdName=ms3297076796458174, createdTime=Tue Nov 09 12:18:17 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507808, encodeId=4ecb150e808d6, content=<a href='/topic/show?id=8764484014' target=_blank style='color:#2F92EE;'>#clinical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4840, encryptionId=8764484014, topicName=clinical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ee59933733, createdName=zll0628, createdTime=Tue Nov 09 12:18:17 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2021-11-09 一闲
  6. [GetPortalCommentsPageByObjectIdResponse(id=2013755, encodeId=1c442013e5537, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Sep 23 21:18:17 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716745, encodeId=84ef1e1674575, content=<a href='/topic/show?id=147c6e238cf' target=_blank style='color:#2F92EE;'>#热疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67238, encryptionId=147c6e238cf, topicName=热疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924b32313941, createdName=zhaohui6742, createdTime=Fri Dec 31 15:18:17 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086209, encodeId=c33920862095a, content=<a href='/topic/show?id=d85c13141c' target=_blank style='color:#2F92EE;'>#4°C#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1314, encryptionId=d85c13141c, topicName=4°C)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Sun Jun 12 17:18:17 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406116, encodeId=8d851406116ec, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47589, encryptionId=a5404e589d7, topicName=局部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d14c2562456, createdName=chg122, createdTime=Tue Nov 09 12:18:17 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408310, encodeId=2e0f140831051, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Tue Nov 09 12:18:17 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443502, encodeId=b099144350252, content=<a href='/topic/show?id=4a65246327c' target=_blank style='color:#2F92EE;'>#人乳头瘤病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24632, encryptionId=4a65246327c, topicName=人乳头瘤病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fb15077773, createdName=ms3297076796458174, createdTime=Tue Nov 09 12:18:17 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507808, encodeId=4ecb150e808d6, content=<a href='/topic/show?id=8764484014' target=_blank style='color:#2F92EE;'>#clinical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4840, encryptionId=8764484014, topicName=clinical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ee59933733, createdName=zll0628, createdTime=Tue Nov 09 12:18:17 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=2013755, encodeId=1c442013e5537, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Sep 23 21:18:17 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716745, encodeId=84ef1e1674575, content=<a href='/topic/show?id=147c6e238cf' target=_blank style='color:#2F92EE;'>#热疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67238, encryptionId=147c6e238cf, topicName=热疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924b32313941, createdName=zhaohui6742, createdTime=Fri Dec 31 15:18:17 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086209, encodeId=c33920862095a, content=<a href='/topic/show?id=d85c13141c' target=_blank style='color:#2F92EE;'>#4°C#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1314, encryptionId=d85c13141c, topicName=4°C)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Sun Jun 12 17:18:17 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406116, encodeId=8d851406116ec, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47589, encryptionId=a5404e589d7, topicName=局部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d14c2562456, createdName=chg122, createdTime=Tue Nov 09 12:18:17 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408310, encodeId=2e0f140831051, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Tue Nov 09 12:18:17 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443502, encodeId=b099144350252, content=<a href='/topic/show?id=4a65246327c' target=_blank style='color:#2F92EE;'>#人乳头瘤病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24632, encryptionId=4a65246327c, topicName=人乳头瘤病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fb15077773, createdName=ms3297076796458174, createdTime=Tue Nov 09 12:18:17 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507808, encodeId=4ecb150e808d6, content=<a href='/topic/show?id=8764484014' target=_blank style='color:#2F92EE;'>#clinical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4840, encryptionId=8764484014, topicName=clinical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ee59933733, createdName=zll0628, createdTime=Tue Nov 09 12:18:17 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2021-11-09 zll0628

相关资讯

JAMA子刊:放心打!HPV疫苗接种后感染力长期持续下降!

宫颈癌是全球女性最常见的癌症之一。

Cell Death Differ:HPV介导EGFR信号转导通路促进宫颈癌细胞的增殖

持续感染人乳头瘤病毒(HPV)是大多数宫颈癌及其他几种肛门生殖器和口咽癌的主要原因。这些癌症主要是由HPV16和HPV18引起的。然而,其他13种高危HPV类型也与癌症的发生发展相关。HPV诱导的恶性

PLOS Medicine:人乳头瘤病毒感染可增加早产风险

人乳头瘤病毒 (HPV) 感染是育龄妇女最常见的生殖器感染。持续性生殖器感染高危 HPV 与宫颈癌及其前体宫颈上皮内瘤变 (CIN)有关。

Br J Cancer:系统性评估和荟萃分析揭示浸润性T细胞标志物在宫颈癌发生中的作用

子宫颈癌作为最常见的妇科肿瘤之一,在全球范围内具有较高的发病率和死亡率,在2018年有超过569,000例病例和311,000例死亡病例。尽管目前在高收入人群中的筛查已大大降低了子宫颈癌的发病率,且随

LANCET:真实世界数据表明,HPV疫苗大幅降低宫颈癌发病率

宫颈癌,是最常见的妇科恶性肿瘤之一。据世界卫生组织国际癌症研究署(IARC)发布的2020年全球最新癌症负担数据,2020年全球新增宫颈癌60万例,新增宫颈癌死亡34万例,发病人数和死亡人数在女性癌症